Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Regeneron Pharmaceuticals Inc. buy Royal Bank of Canada

Regeneron Pharmaceuticals Inc.
Start price
€915.60
04.06.24 / 50%
Target price
€1,103.8
04.06.25
Performance (%)
-53.36%
End price
€427.00
05.06.25
Summary
This prediction ended on 05.06.25 with a price of €427.00. Massive losses of -53.36% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. A total of €1.72 was paid as dividends for this prediction. Royal_Bank_of_Canada has 50% into this prediction

Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.

Performance without dividends (%)
Name 1w 1m 1y
Regeneron Pharmaceuticals Inc. -6.644% -6.644% -20.241%
iShares Core DAX® 1.659% 1.586% 18.113%
iShares Nasdaq 100 0.381% 1.900% 8.877%
iShares Nikkei 225® 2.102% -1.377% 13.281%
iShares S&P 500 0.221% 1.258% 3.556%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Regeneron Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -53.36%
Target price 1103.760
Change
Ends at 04.06.25

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Royal Bank of Canada from $1,185.00 to $1,200.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat

Royal Bank of Canada 
0
Report Share
04.06.24
In the thread Trading Regeneron Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -53.36%
Target price 1103.760
Change
Ends at 04.06.25

Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

Royal Bank of Canada 
0
Report Share
05.06.25

Current prediction by Royal_Bank_of_Canada for Regeneron Pharmaceuticals Inc.

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€519.00
30.04.25
€829.37
30.04.26
14.96%
14:44

Royal Bank of Canada 
30.04.25 50%

Stopped prediction by Royal_Bank_of_Canada for Regeneron Pharmaceuticals Inc.

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€528.00
27.05.25
€827.67
27.05.26
12.83%
14:44

Royal Bank of Canada 
27.05.25 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€779.00
01.11.24
€1,120.6
01.11.25
-27.09%
02.11.25

Royal Bank of Canada 
01.11.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€882.60
22.10.24
€1,166.0
22.10.25
-43.21%
23.10.25

Royal Bank of Canada 
22.10.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€923.80
04.10.24
€1,149.5
04.10.25
-44.27%
05.10.25

Royal Bank of Canada 
04.10.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€915.20
24.09.24
€1,121.8
24.09.25
-46.50%
25.09.25

Royal Bank of Canada 
24.09.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1,023.5
17.09.24
€1,152.6
17.09.25
-51.18%
18.09.25

Royal Bank of Canada 
17.09.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1,036.0
05.09.24
€1,125.8
05.09.25
-52.50%
06.09.25

Royal Bank of Canada 
05.09.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€990.00
02.08.24
€1,136.2
02.08.25
-51.29%
03.08.25

Royal Bank of Canada 
02.08.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€993.60
24.06.24
€1,145.1
24.06.25
-54.51%
25.06.25

Royal Bank of Canada 
24.06.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€941.80
12.06.24
€1,134.9
12.06.25
-52.33%
13.06.25

Royal Bank of Canada 
12.06.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€871.20
09.04.24
€1,092.5
09.04.25
-39.42%
10.04.25

Royal Bank of Canada 
09.04.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€911.50
27.02.24
€1,091.9
27.02.25
-25.40%
28.02.25

Royal Bank of Canada 
27.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€868.50
05.02.24
€1,034.6
05.02.25
-20.12%
06.02.25

Royal Bank of Canada 
05.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€877.50
29.01.24
€995.08
29.01.25
-24.79%
30.01.25

Royal Bank of Canada 
29.01.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€850.00
12.01.24
€981.74
12.01.25
-19.91%
13.01.25

Royal Bank of Canada 
12.01.24 50%